Conversion hepatectomy for huge hepatocellular carcinoma with arterioportal shunt after chemoembolization and lenvatinib therapy

N Sato, T Beppu, K Kinoshita, H Yuki… - Anticancer …, 2019 - ar.iiarjournals.org
Large tumor size and arterioportal shunt are poor prognostic factors for hepatocellular
carcinoma. Lenvatinib is a novel and potent multi-tyrosine kinase inhibitor developed in …

Vater Papilla-preserving Strategy for Advanced Hepatocellular Carcinoma With Excessive Bile Duct Tumor Thrombus

K Yamamura, T Beppu, K Inoue… - Anticancer …, 2022 - ar.iiarjournals.org
Abstract Background/Aim: Hepatocellular carcinoma (HCC) with bile duct tumor thrombus
(BDTT) is highly malignant; therefore, continual, multidisciplinary treatments are essential …

Predicting poorly differentiated hepatocellular carcinoma that meets the milan criteria

Y Koga, T Beppu, T Miyata, Y Kitano, A Tsuji… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: Poorly differentiated hepatocellular carcinoma (HCC) is a malignant
phenotype following radiofrequency ablation, but not liver resection. This study aimed to …

Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a …

K Yamamura, T Beppu, N Sato, E Oda… - Clinical Journal of …, 2021 - Springer
Multidisciplinary treatment is recommended for the management of patients with advanced
hepatocellular carcinoma (HCC). Some operative decollateralization of extrahepatic feeding …

[HTML][HTML] Multi-parameter ultrasound based on the logistic regression model in the differential diagnosis of hepatocellular adenoma and focal nodular hyperplasia

M Wu, RH Zhou, F Xu, XP Li, P Zhao… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Focal nodular hyperplasia (FNH) has very low potential risk, and a
tendency to spontaneously resolve. Hepatocellular adenoma (HCA) has a certain malignant …

Waiting-time and quality of care deserved to patients with early stage hepatocellular carcinoma undergoing RFA treatment

M Soresi, A Licata, L Giannitrapani… - Annals of …, 2017 - medigraphic.com
Hepatocellular carcinoma (HCC) accounts for 70%-90% of primary liver cancers, and is the
fifth most common cancer in Western countries. 1 HCC is a rapidly evolving tumor, with …

[PDF][PDF] Tumor: Life Retrogression?

XZ Wu, HR Zhang - TMR Theory and Hypothesis, 2018 - tmrjournals.cn
Cancer emerged in human history for centuries. It seems that while human beings are
evolving, tumors are always on their heels. In order to explain and study the mechanism of …